Fluorescent in situ Sequencing (FISSEQ): Principle and Innovation
Fluorescent in situ Sequencing (FISSEQ) is a revolutionary technique that fundamentally transforms how researchers study gene expression, merging the global transcriptome analysis capabilities of RNA sequencing (RNA-seq) with the spatial resolution of traditional in situ hybridization (ISH). Unlike conventional RNA-seq, which requires physically disrupting cells and tissues to extract RNA, thereby losing all information about the original location of the transcripts, FISSEQ allows the direct sequencing of RNA molecules *within* intact biological samples, such as fixed cells, tissue sections, and whole-mount embryos. This capability generates a high-resolution, three-dimensional map of the transcriptome, providing not only *what* genes are expressed but precisely *where* they are located within the cell or tissue architecture. Developed in the laboratory of George Church at the Wyss Institute, FISSEQ effectively treats the biological sample itself as a custom sequencing chip, paving the way for a deeper understanding of how cellular phenotype, environment, and spatial organization influence gene regulation and function in health and disease.
The Foundational Principle: Combining Amplification and Location
The core principle of FISSEQ is to convert the transient, low-abundance RNA transcripts into stable, localized, and highly-amplified DNA copies that can be subjected to cyclic sequencing chemistry while remaining fixed in place. The entire methodology is a sophisticated interplay of enzymatic biochemistry and advanced fluorescence microscopy. The process is based on creating a spatially structured sequencing library directly inside the fixed cells. By generating many copies of the original complementary DNA (cDNA) sequence at the transcript’s exact location, the signal is amplified dramatically. This amplification overcomes the limitations of optical resolution and the intrinsically noisy signal associated with single molecule detection, allowing for accurate identification of gene transcripts even in densely packed cellular environments. The sequence information is then gathered through an intensive, iterative protocol of biochemical reactions interlaced with high-resolution imaging, essentially replicating the process of a commercial bulk DNA sequencing machine, but performed within the fixed biological matrix.
Detailed Steps of the FISSEQ Methodology
The FISSEQ protocol is fundamentally divided into two major phases: the preparation of the in situ sequencing library and the cyclic sequencing and imaging process.
The library construction phase begins with **Sample Preparation** where cells or tissue sections are fixed to preserve their morphological integrity. Next, **Reverse Transcription and Crosslinking** occur. The RNA molecules are reverse transcribed into cDNA using tagged random hexamer primers, often incorporating chemically modified nucleotides such as aminoallyl dUTP. Following this, the newly synthesized cDNA strands are permanently **cross-linked** to the surrounding cellular protein matrix using chemical agents (like BS(PEG)9). This cross-linking step is crucial as it stabilizes the cDNA amplicons, locking them into their original spatial coordinates within the fixed tissue, thereby creating the stable sequencing library.
This is followed by **Circularization and Rolling Circle Amplification (RCA)**. The cross-linked cDNA fragments are circularized, and then the enzyme Phi29 DNA polymerase uses the circular template to perform RCA, generating numerous identical copies of the parent cDNA molecule. These copies form a dense, localized cluster known as a “nanoball” or “rolony,” which can range from 200 to 400 nm in diameter. The high number of copies within each rolony ensures the sequencing signal is strong enough to be detected.
The second phase, **Sequencing and Analysis**, is iterative. It primarily utilizes the sequencing-by-ligation method, which is conceptually identical to the SOLiD sequencing platform. In each cycle, a sequencing primer binds to an adapter sequence within the rolony. Fluorescently labeled oligonucleotide probes are then sequentially hybridized and ligated to the amplified DNA strands. The color of the ligated probe corresponds to the identity of one or two adjacent bases in the sequence. After ligation, the entire sample is imaged using a multi-channel confocal microscope to capture the color and 3D location of every rolony. The fluorescent tag is then cleaved or quenched, and the process is repeated for subsequent sequencing cycles. Typically, 30 cycles are performed to yield a 30-base sequence read for each transcript. Finally, **Image Analysis and Data Analysis** utilize advanced computational tools to process the millions of images, register the sequence of colors for each localized spot, decode the nucleotide sequence, and map these sequences to their precise spatial coordinates within the original tissue image, creating the final spatially resolved transcriptome map. Techniques like ‘partition sequencing’ may also be used during the process to reduce the number of molecular reactions for densely packed regions, ensuring individual rolonies remain discernible.
Advantages and Comprehensive Uses of FISSEQ
FISSEQ offers multiple advantages that distinguish it from predecessor techniques. Firstly, its most significant strength is the joint, high-throughput readout of **sequence and spatial information**, something traditional bulk RNA-seq and low-multiplex ISH methods cannot achieve simultaneously. It allows for **genome-wide profiling** (sequencing thousands of genes) while completely **preserving the tissue architecture** and single-cell context. The in situ amplification and the use of sequencing-by-ligation chemistry dramatically improve the **signal-to-noise ratio**; the sequence information itself is used to identify true nucleic acid objects, effectively eliminating background noise, autofluorescence, and debris that often plague analog intensity-based imaging methods. This provides the ability to detect even faint or low-abundance transcripts with high fidelity and allows for **single-cell sequencing** in its native environment.
The capacity to provide this spatially resolved and high-throughput data has opened up numerous **Applications** in research. In **Neurobiology and Brain Research**, FISSEQ is being used to map neuronal connections, understand the spatial organization of mRNAs within different brain regions, and elucidate the pathogenesis of neurological disorders. In **Cancer Research**, it helps track how gene mutations impact local cancer invasion and metastasis, better define therapeutic responses, and uncover novel drug targets by providing a molecular atlas of the tumor microenvironment. More broadly, FISSEQ is critical for **Embryonic Development** studies, allowing researchers to visualize the spatial organization of mRNAs that relate to stem cell differentiation and tissue morphogenesis. Furthermore, its ability to sequence nucleic acids directly in tissue can be employed for the **detection of pathogens** (like microbial RNA sequences) directly within infected host cells, making it a powerful tool for infectious disease diagnostics and research.